Changes in bone density and bone turnover in patients with rheumatoid arthritis treated with rituximab, a B cell depleting antibody
Not Applicable
Completed
- Conditions
- Rheumatoid arthritisMusculoskeletal DiseasesOther rheumatoid arthritis
- Registration Number
- ISRCTN82317088
- Lead Sponsor
- South Tees Hospitals NHS Foundation Trust (UK)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 46
Inclusion Criteria
1. Age 18 or older
2. Established diagnosis of rheumatoid arthritis
3. Eligible for treatment with rituximab
4. Written informed consent
Exclusion Criteria
1. Concurrent bisphosphonate use
2. Poor previous compliance
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method